Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2002
10/31/2002WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002WO2002085903A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/31/2002WO2002085901A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
10/31/2002WO2002085896A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
10/31/2002WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002WO2002085866A1 Novel compounds
10/31/2002WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002WO2002085850A1 Cyclic amidine derivative
10/31/2002WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085365A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors
10/31/2002WO2002085357A1 Nociceptin analogs
10/31/2002WO2002085356A1 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors
10/31/2002WO2002085355A1 Spiropyrazole compounds
10/31/2002WO2002085353A1 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor xa inhibitors
10/31/2002WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002WO2002067654A3 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
10/31/2002WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002US20020161231 Intermediate for preparing camptothecin derivatives
10/31/2002US20020161228 Piperidine compounds
10/31/2002US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002US20020161029 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002US20020161022 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/31/2002US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
10/31/2002US20020161005 Nitrogen heterocycle compounds
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020160994 The beta-hydroxy lactone, such as -(+)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H -oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione
10/31/2002US20020160988 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
10/31/2002US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2444571A1 1, 4, 5, 6-tetrahydropyrazolo-¬3, 4-c|-pyridin-7-ones as factor xa inhi bitors
10/31/2002CA2444570A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors
10/31/2002CA2444381A1 Novel compounds
10/31/2002CA2444214A1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2441772A1 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors
10/31/2002CA2439960A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists)
10/30/2002EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002EP1252161A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
10/30/2002EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251854A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
10/30/2002EP1155018B1 Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8- diazabicyclo - 4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic
10/30/2002EP1105368B1 Photoactivatable bases containing nitrogen
10/30/2002EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377351A Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient
10/30/2002CN1377350A Process for production of naphthyridine-3-carboxylic acid derivatives
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377270A B-carboline drug products
10/30/2002CN1377269A Vitronectin receptor antagonists
10/30/2002CN1093534C Cationic polypeptide condensting agent of pyridine, its synthesis and application
10/29/2002US6472404 HIV protease inhibitors
10/29/2002US6472403 αV integrin receptor antagonists
10/29/2002US6472402 Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
10/29/2002US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002US6472388 Psychotherapeutic agents.
10/29/2002US6472205 Expression control sequences adapted for function in eukaryotic cell, operably linked to sequence coding cytosolic beta-lactamase; screening by contacting host cell with membrane permeable, fluorescent substrate of beta-lactamase
10/28/2002WO2001082909A2 2-acyl indol derivatives and their use as anti-tumour agents
10/28/2002CA2407677A1 2-acyl indol derivatives and their use as anti-tumour agents
10/24/2002WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002WO2002083683A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002WO2002083680A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002WO2002083673A1 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
10/24/2002WO2002083672A1 Antiviral pyrazolopyridine compounds
10/24/2002WO2002083671A1 Mercaptoacetylamide derivatives, a process for their preparation and their use
10/24/2002WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083645A1 Novel compounds
10/24/2002WO2002083175A1 Visual function improving agents
10/24/2002WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002WO2002083143A1 Cxcr3 antagonists
10/24/2002WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002WO2002083125A1 Method of inhibiting adhesion formation
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002067999A3 Actinium-225 complexes and conjugates for targeted radiotherapy
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002WO2002030931A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
10/24/2002WO2001053299A9 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
10/24/2002US20020156285 Novel herbicides
10/24/2002US20020156280 Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
10/24/2002US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002US20020156092 Ligands for G-protein-coupled receptors and opiod receptors; analgesics, treating drug addiction, or tinnitus
10/24/2002US20020156083 3-hetero-arylidene-2-indolinone compounds; anticancer agents
10/24/2002US20020156015 Reversal of multidrug resistance in human colon carcinoma cells
10/24/2002CA2444596A1 Large conductance calcium-activated k channel opener
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 646